Creades AB Series A (LSE:0QI9) — Market Cap & Net Worth
Market Cap & Net Worth: Creades AB Series A (0QI9)
Creades AB Series A (LSE:0QI9) has a market capitalization of $106.91 Million (Skr993.47 Million) as of June 16, 2026. Listed on the LSE stock exchange, this UK-based company holds position #19038 globally and #110 in its home market, demonstrating a 5.63% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Creades AB Series A's stock price Skr79.70 by its total outstanding shares 12465100 (12.47 Million). Review debt load of Creades AB Series A to assess the company's total debt and financial obligations.
Creades AB Series A Market Cap History: 2016 to 2026
Creades AB Series A's market capitalization history from 2016 to 2026. Data shows growth from $19.81 Million to $106.91 Million (18.44% CAGR).
Creades AB Series A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Creades AB Series A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.91x
Creades AB Series A's market cap is 0.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.08x
Creades AB Series A's market cap is 0.08 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $19.81 Million | $948.00 Million | $325.00 Million | 0.02x | 0.06x |
| 2017 | $32.07 Million | $1.24 Billion | $260.00 Million | 0.03x | 0.12x |
| 2018 | $33.68 Million | $950.00 Million | $532.00 Million | 0.04x | 0.06x |
| 2019 | $57.98 Million | $725.00 Million | $1.09 Billion | 0.08x | 0.05x |
| 2020 | $117.62 Million | $159.00 Million | $3.65 Billion | 0.74x | 0.03x |
| 2021 | $186.46 Million | $139.00 Million | $4.19 Billion | 1.34x | 0.04x |
| 2022 | $100.76 Million | $-4.20 Billion | -$3.95 Billion | -0.02x | N/A |
| 2023 | $94.33 Million | $509.00 Million | $558.00 Million | 0.19x | 0.17x |
| 2024 | $96.79 Million | $1.26 Billion | $1.20 Billion | 0.08x | 0.08x |
| 2025 | $100.41 Million | $110.00 Million | $1.21 Billion | 0.91x | 0.08x |
Competitor Companies of 0QI9 by Market Capitalization
Companies near Creades AB Series A in the global market cap rankings as of June 16, 2026.
Key companies related to Creades AB Series A by market ranking:
- Aspen Group Ltd (TA:ASGR): Ranked #19029 globally with a market cap of $107.01 Million USD ( ILA39.91 Billion ILA).
- Volati AB (ST:VOLO-PREF): Ranked #19030 globally with a market cap of $107.01 Million USD ( Skr994.34 Million SEK).
- Singha Estate Public Company Limited (BK:S): Ranked #19039 globally with a market cap of $106.81 Million USD ( ฿3.43 Billion THB).
- Cognition Therapeutics Inc (NASDAQ:CGTX): Ranked #19040 globally with a market cap of $106.81 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #19029 | Aspen Group Ltd | TA:ASGR | $107.01 Million | ILA620.70 |
| #19030 | Volati AB | ST:VOLO-PREF | $107.01 Million | Skr620.00 |
| #19039 | Singha Estate Public Company Limited | BK:S | $106.81 Million | ฿0.50 |
| #19040 | Cognition Therapeutics Inc | NASDAQ:CGTX | $106.81 Million | $1.21 |
Creades AB Series A Historical Marketcap From 2016 to 2026
Between 2016 and today, Creades AB Series A's market cap moved from $19.81 Million to $ 106.91 Million, with a yearly change of 18.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr106.91 Million | +6.48% |
| 2025 | Skr100.41 Million | +3.74% |
| 2024 | Skr96.79 Million | +2.60% |
| 2023 | Skr94.33 Million | -6.39% |
| 2022 | Skr100.76 Million | -45.96% |
| 2021 | Skr186.46 Million | +58.52% |
| 2020 | Skr117.62 Million | +102.88% |
| 2019 | Skr57.98 Million | +72.15% |
| 2018 | Skr33.68 Million | +5.03% |
| 2017 | Skr32.07 Million | +61.90% |
| 2016 | Skr19.81 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Creades AB Series A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $106.91 Million USD |
| MoneyControl | $106.91 Million USD |
| MarketWatch | $106.91 Million USD |
| marketcap.company | $106.91 Million USD |
| Reuters | $106.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Creades AB Series A
Creades AB is a private equity and venture capital investment firm specializing in early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK50 million ($4.78 million) and SEK500 million ($47.91 million). Th… Read more